Islet amyloid and fibrosis in the cardiometabolic syndrome and type 2 diabetes mellitus.
Hayden
Melvin R
MR
Department of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Missouri School of Medicine, Columbia, MO 65212, USA. mrh29@usmo.com
D000682:Amyloid / Q000032:analysis*; D000818:Animals; D002318:Cardiovascular Diseases / Q000150:complications*; D004396:Coloring Agents; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004195:Disease Models, Animal; D005260:Female; D005355:Fibrosis; D006801:Humans; D007150:Immunohistochemistry; D007515:Islets of Langerhans / Q000473:pathology*; D024821:Metabolic Syndrome / Q000473:pathology*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000473:pathology; D051381:Rats; D011924:Rats, Zucker
D000682:Amyloid; D004396:Coloring Agents